Nachrichten zur GlycoMimetics Inc. Aktie

Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors…

Crescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 Million

Advancing Lead Program, CR-001, a PD-1 x VEGF Bispecific Antibody, and Developing Pipeline of Novel ADCs as Single Agents and…

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. – GLYC

NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has…

GlycoMimetics, Inc. (GLYC) Corporate Update Call Transcript

…

GlycoMimetics: Is No News Bad News?

…

GlycoMimetics, Inc. (GLYC) Q4 2023 Earnings Call Transcript

…

GlycoMimetics Can Become A Game Changer In Blood Cancers

…